Private Wealth Advisors (Pennsylvania)’s Gilead Sciences GILD Stock Holding History

Private Wealth Advisors (Pennsylvania)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-6,979	Closed	-$474K	–	125
2017 Q1	$474K	Sell	6,979 -6,030	-46%	-$424K	0.21%	90
2016 Q4	$932K	Sell	13,009 -864	-6%	-$64.2K	0.43%	66
2016 Q3	$1.1M	Sell	13,873 -345	-2%	-$28K	0.52%	54
2016 Q2	$1.19M	Buy	14,218 +257	+2%	+$22.8K	0.58%	49
2016 Q1	$1.28M	Buy	13,961 +627	+5%	+$56.5K	0.68%	47
2015 Q4	$1.35M	Sell	13,334 -1,813	-12%	-$189K	0.76%	44
2015 Q3	$1.49M	Buy	+15,147	New	+$1.68M	0.74%	42

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Private Wealth Advisors (Pennsylvania)'s GILD Position: Q2 2017 in Review

Private Wealth Advisors (Pennsylvania) sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 6,979 shares — an estimated $474K sold.

Private Wealth Advisors (Pennsylvania) first reported a position in GILD in Q3 2015 and held it in 7 quarters. The position peaked at $1.49M in Q3 2015. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

Private Wealth Advisors (Pennsylvania) reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
Private Wealth Advisors (Pennsylvania) sold 6,979 Gilead Sciences shares in Q2 2017, an estimated $474K.
Private Wealth Advisors (Pennsylvania) first reported a position in Gilead Sciences in Q3 2015 and held it in 7 quarters.
Private Wealth Advisors (Pennsylvania)'s Gilead Sciences position peaked at $1.49M in Q3 2015.
1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Private Wealth Advisors (Pennsylvania)'s 13F filing for Q2 2017, filed 10 Aug 2017.